Workflow
鄂尔多斯(600295) - 2024 Q1 - 季度财报
ERDOSERDOS(SH:600295)2024-04-29 08:09

Financial Performance - The company's operating revenue for Q1 2024 was CNY 670,090.87 million, a decrease of 11.00% compared to CNY 752,935.60 million in the same period last year[5] - Net profit attributable to shareholders was CNY 34,658.51 million, down 65.36% from CNY 100,839.47 million year-on-year[5] - Basic and diluted earnings per share were both CNY 0.12, reflecting a decline of 66.67% from CNY 0.36 in the same period last year[6] - The weighted average return on equity was 1.61%, down from 4.82% year-on-year[6] - The decline in net profit was primarily due to a decrease in market sales prices of silicon iron, PVC, and polysilicon products[9] - Total operating revenue for Q1 2024 was CNY 6,700,908,686.25, a decrease of 11.0% compared to CNY 7,529,356,036.09 in Q1 2023[19] - Net profit for Q1 2024 was CNY 397,157,114.31, a significant decline of 70.2% from CNY 1,332,058,454.55 in Q1 2023[21] - The total comprehensive income for Q1 2024 was CNY 395,503,876.22, down from CNY 1,331,809,609.02 in Q1 2023, indicating a decline of 70.3%[21] - The total comprehensive income attributable to the parent company's owners for Q1 2024 is CNY 345,498,516.78, compared to CNY 1,000,204,337.55 in Q1 2023, reflecting a significant decrease[22] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 37.28% to CNY 48,694.00 million, compared to CNY 77,804.08 million in the previous year[5] - Cash inflow from operating activities for Q1 2024 is CNY 6,012,683,469.34, slightly down from CNY 6,031,595,744.83 in Q1 2023[23] - Net cash flow from operating activities decreased to CNY 486,940,012.92 in Q1 2024 from CNY 776,373,754.22 in Q1 2023[23] - Cash inflow from financing activities in Q1 2024 totals CNY 1,599,296,529.61, down from CNY 2,617,675,054.69 in Q1 2023[24] - The net cash flow from financing activities for Q1 2024 is -CNY 649,373,774.88, compared to -CNY 450,458,809.73 in Q1 2023[24] - The company's cash and cash equivalents decreased to CNY 4.74 billion from CNY 5.91 billion, representing a decline of approximately 19.8%[14] - The company's cash inflow from operating activities totaled CNY 590,381,344.15 in Q1 2024, compared to CNY 543,419,681.47 in Q1 2023, marking an increase of 8.6%[31] - The net increase in cash and cash equivalents was -76,409,426.35, contrasting with an increase of 311,052,997.90 in the previous period[32] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,859,245.93 million, a slight increase of 0.05% from CNY 4,911,787.71 million at the end of the previous year[6] - The equity attributable to shareholders increased by 1.85% to CNY 2,166,479.16 million from CNY 2,142,589.32 million at the end of the previous year[6] - The company's total liabilities decreased to CNY 21,743,198,738.30 in Q1 2024 from CNY 22,174,576,125.04 in Q1 2023, a reduction of 1.9%[18] - The total liabilities decreased to CNY 2,113,297,190.47 in Q1 2024 from CNY 2,183,110,074.54 in Q1 2023, reflecting a reduction of approximately 3.2%[29] - The company's total assets amounted to approximately CNY 48.59 billion, a slight increase from CNY 48.57 billion at the end of 2023[14] - The total assets of the company as of Q1 2024 were CNY 48,592,459,332.92, slightly up from CNY 48,568,351,458.37 in Q1 2023[18] Investments and Acquisitions - The company completed the acquisition of 100% equity in Tianjin Xingyue Puyun Technology Co., Ltd. and Etuokeqi Yiran Agricultural and Animal Husbandry Co., Ltd. in December 2023, leading to retrospective adjustments in financial statements[6] - The company reported investment income of CNY 262,046,275.98 in Q1 2024, a decrease of 46.0% compared to CNY 492,348,818.53 in Q1 2023[21] - The investment income for Q1 2024 was a loss of CNY 10,158,216.79, compared to a profit of CNY 17,076,318.09 in Q1 2023, indicating a substantial decline[29] Research and Development - Research and development expenses for Q1 2024 were CNY 30,563,499.98, down 17.0% from CNY 37,071,368.21 in Q1 2023[19] - The company's research and development expenses for Q1 2024 were CNY 18,458,168.50, up from CNY 17,769,178.49 in Q1 2023, showing a growth of 3.9%[29] Other Financial Metrics - Non-recurring gains and losses included a loss of CNY 12,999,051.50 million from fair value changes of financial assets and liabilities[7] - The company's short-term borrowings decreased to CNY 2.10 billion from CNY 2.73 billion, a decline of approximately 23.2%[16] - The company's long-term equity investments rose to CNY 11.84 billion from CNY 11.69 billion, showing an increase of about 1.3%[16] - The company reported a significant increase in goodwill, rising to CNY 55.21 million from CNY 4.79 million, a growth of approximately 1,151.4%[16] - The company's financial liabilities included CNY 98,500,000.00 in notes payable, an increase from CNY 70,000,000.00 in the previous year[29] - The company has not disclosed any new product developments or market expansion strategies in the current report[13]